These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18034767)

  • 1. Anti-beta 2 glycoprotein I antibodies and the risk of myocardial infarction in young premenopausal women.
    Meroni PL; Peyvandi F; Foco L; Bernardinelli L; Fetiveau R; Mannucci PM; Tincani A
    J Thromb Haemost; 2007 Dec; 5(12):2421-8. PubMed ID: 18034767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-beta 2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease.
    Salobir B; Sabovic M; Hojnik M; Cucnik S; Kveder T
    Immunobiology; 2007; 212(3):193-9. PubMed ID: 17412286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated IgA antiphospholipid antibodies in healthy pregnant women in Sudan but not Sweden, without corresponding increase in IgA anti-β
    Elbagir S; Mohammed NA; Kaihola H; Svenungsson E; Gunnarsson I; Manivel VA; Pertsinidou E; Elagib EM; Nur MAM; Elussein EA; Elshafie A; Åkerud H; Rönnelid J
    Lupus; 2020 Apr; 29(5):463-473. PubMed ID: 32106789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-beta2 glycoprotein-I antibody increases the risk of pregnancy-induced hypertension: a case-controlled study.
    Yamada H; Atsumi T; Amengual O; Koike T; Furuta I; Ohta K; Kobashi G
    J Reprod Immunol; 2010 Jan; 84(1):95-9. PubMed ID: 20004024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases.
    Gatto M; Perricone C; Tonello M; Bistoni O; Cattelan AM; Bursi R; Cafaro G; De Robertis E; Mencacci A; Bozza S; Vianello A; Iaccarino L; Gerli R; Doria A; Bartoloni E
    Clin Exp Rheumatol; 2020; 38(4):754-759. PubMed ID: 32723434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibodies in acute coronary syndrome.
    Veres K; Lakos G; Kerényi A; Szekanecz Z; Szegedi G; Shoenfeld Y; Soltész P
    Lupus; 2004; 13(6):423-7. PubMed ID: 15303568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.
    Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M
    Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity.
    de Larrañaga GF; Forastiero RR; Martinuzzo ME; Carreras LO; Tsariktsian G; Sturno MM; Alonso BS
    Lupus; 2000; 9(8):594-600. PubMed ID: 11035434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
    Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
    Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
    Chayoua W; Kelchtermans H; Moore GW; Musiał J; Wahl D; de Laat B; Devreese KMJ
    J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between IgG and IgM antibodies against cardiolipin, β2-glycoprotein I and Domain I of β2-glycoprotein I with disease profile in patients with multiple sclerosis.
    Filippidou N; Krashias G; Pericleous C; Rahman A; Ioannou Y; Giles I; Demetriou C; Anatolitou A; Christodoulou C; Pantzaris M; Lambrianides A
    Mol Immunol; 2016 Jul; 75():161-7. PubMed ID: 27289032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High IgA antiphospholipid autoantibodies in healthy Sudanese explain the increased prevalence among Sudanese compared to Swedish systemic lupus erythematosus patients.
    Elbagir S; Elshafie AI; Elagib EM; Mohammed NA; Aledrissy MI; Manivel VA; Pertsinidou E; Nur MA; Gunnarsson I; Svenungsson E; Rönnelid J
    Lupus; 2020 Oct; 29(11):1412-1422. PubMed ID: 32741301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome.
    Nuri E; Taraborelli M; Andreoli L; Tonello M; Gerosa M; Calligaro A; Argolini LM; Kumar R; Pengo V; Meroni PL; Ruffatti A; Tincani A
    Immunol Res; 2017 Feb; 65(1):17-24. PubMed ID: 27406736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to the atheroma component beta2-glycoprotein I and risk of symptomatic peripheral artery disease.
    Franck M; Staub HL; Petracco JB; Norman GL; Lassen AJ; Schiavo N; Borges RB; von Mühlen CA
    Angiology; 2007; 58(3):295-302. PubMed ID: 17626983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies.
    Metzger J; von Landenberg P; Kehrel M; Buhl A; Lackner KJ; Luppa PB
    Clin Chem; 2007 Jun; 53(6):1137-43. PubMed ID: 17434906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
    Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
    Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of anti-β2-glycoprotein I domain I and anti-phosphatidylserine/prothrombin antibodies suggests strong thrombotic risk.
    Lee JS; Gu J; Park HS; Yoo HJ; Kim HK
    Clin Chem Lab Med; 2017 May; 55(6):882-889. PubMed ID: 28002027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unique antiphospholipid assay recognizing phospholipid mixture compared with criteria antiphospholipid immunoassays in lupus patients.
    Zuo Y; Willis R; Papalardo E; Petri M; Harris EN; Schleh A; DeCeulaer K; Smikle M; Vilá LM; Reveille JD; Alarcón GS; Gonzalez EB
    Lupus; 2017 May; 26(6):606-615. PubMed ID: 27753626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein I antibodies. A comparison with a homemade ELISA method.
    Meneghel L; Ruffatti A; Gavasso S; Tonello M; Mattia E; Spiezia L; Campello E; Hoxha A; Fedrigo M; Punzi L; Simioni P
    Clin Chem Lab Med; 2015 Jun; 53(7):1083-9. PubMed ID: 25720075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.